Telmisartan for Treatment of COVID-19 Patients

Clinical trial NCT04355936 · COMPLETED

Trial details

NCT number: NCT04355936
Sponsor: Laboratorio Elea Phoenix S.A.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Drug Treatment

Start date: 2020-05-19
Primary completion: 2020-11-02
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.